Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.7450
+0.0050 (0.68%)
Aug 21, 2026, 3:57 PM AEST
Nyrada Market Cap
Nyrada has a market cap or net worth of 183.94 million as of August 21, 2026. Its market cap has increased by 186.47% in one year.
Market Cap
183.94M
Enterprise Value
176.81M
Revenue
2.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.75
ChartMarket Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 183.94M, an increase of 615.56%. That is a compound annual growth rate of 34.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 183.94M | -32.49% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 341.09M |
| Tetratherix | 320.45M |
| Orthocell | 216.44M |
| BLS Pharmaceuticals | 213.88M |
| Dimerix | 177.12M |
| Actinogen Medical | 160.95M |
| Island Pharmaceuticals | 134.64M |
| Recce Pharmaceuticals | 113.80M |